SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001448788-20-000016
Filing Date
2020-12-11
Accepted
2020-12-11 13:06:13
Documents
96
Period of Report
2020-10-31

Document Format Files

Seq Description Document Type Size
1 SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q suwn10-q.htm 10-Q 1061699
2 SECTION 302 CERTIFICATE OF CHIEF EXECUTIVE OFFICER exh31-1.htm EX-31.1 7670
3 SECTION 302 CERTIFICATE OF CHIEF FINANCIAL OFFICER exh31-2.htm EX-31.2 7700
4 SECTION 906 CERTIFICATE OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER exh32-1.htm EX-32.1 5275
  Complete submission text file 0001448788-20-000016.txt   3661828

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT suwn-20201031.xml EX-101.INS 497572
6 XBRL TAXONOMY EXTENSION SCHEMA suwn-20201031.xsd EX-101.SCH 75909
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE suwn-20201031_cal.xml EX-101.CAL 22623
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE suwn-20201031_def.xml EX-101.DEF 37250
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE suwn-20201031_lab.xml EX-101.LAB 250107
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE suwn-20201031_pre.xml EX-101.PRE 193936
Mailing Address 6 SHENGWANG AVENUE, QUFU, SHANDONG F4 273100
Business Address 6 SHENGWANG AVENUE, QUFU, SHANDONG F4 273100 (86) 537-4424999
SUNWIN STEVIA INTERNATIONAL, INC. (Filer) CIK: 0000806592 (see all company filings)

IRS No.: 562416925 | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-53595 | Film No.: 201383089
SIC: 2834 Pharmaceutical Preparations